PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
11 hedge funds and large institutions have $1.52M invested in Provention Bio, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 6 reducing their positions, and 2 closing their positions.
Holders
11
Holders Change
–
Holders Change %
0%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCP
1
Silverleafe Capital Partners
Germantown,
Tennessee
|
$46K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$39K |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$1.12M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $1.12M | 486,618 | +600 | +0.1% |
|
2
Point72 Asset Management
Stamford,
Connecticut
| $131K | 56,751 | – | – |
|
3
Lido Advisors
Los Angeles,
California
| $61K | 26,800 | – | – |
|
4
BlackRock
New York
| $57K | 24,639 | -1,596 | -6% |
|
|
SCP
5
Silverleafe Capital Partners
Germantown,
Tennessee
| $46K | 20,000 | +20,000 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $39K | 16,864 | +16,864 | New |
|
7
Goldman Sachs
New York
| $36K | 15,727 | -4,008 | -20% |
|
|
AIM
8
Alambic Investment Management
Belvedere,
California
| $30K | 13,189 | -3,300 | -20% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $2K | 960 | -2,257 | -70% |
|
|
CSS
10
Cubist Systematic Strategies
Stamford,
Connecticut
| $1K | 500 | -950 | -66% |
|
11
Morgan Stanley
New York
| $0 | 50 | -1,212 | -96% |
|
12
Bank of America
Charlotte,
North Carolina
| – | – | -739 | Closed |
|
13
JPMorgan Chase & Co
New York
| – | – | -60 | Closed |
|
|
CFGS
14
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|